Pasquale Maria E 4

Accession 0001209191-23-005896

CIK 0000879169other

View on SEC.gov Company Profile

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:00 PM ET

Size

36.7 KB

Accession

0001209191-23-005896

Insider Transaction Report

Form 4

Period: 2023-01-30

INCYTE CORPINCY

Pasquale Maria E

EVP & General Counsel

Transactions

Exercise/Conversion
Common Stock
2023-01-30$65.36/sh+12,865$840,856→ 81,389 total
Sale
Common Stock
2023-01-30$84.70/sh−10,438$884,099→ 68,524 total
Exercise/Conversion
Common Stock
2023-01-30$83.58/sh+5,644$471,726→ 74,168 total
Sale
Common Stock
2023-01-30$85.07/sh−5,644$480,135→ 68,524 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-01-30−10,438→ 0 total
Exercise: $68.62Exp: 2028-07-01→ Common Stock (10,438 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-01-30−14,374→ 0 total
Exercise: $80.50Exp: 2030-01-16→ Common Stock (14,374 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-01-30−4,842→ 0 total
Exercise: $74.78Exp: 2032-01-18→ Common Stock (4,842 underlying)
Sale
Common Stock
2023-01-30$84.69/sh−12,865$1,089,537→ 68,524 total
Exercise/Conversion
Common Stock
2023-01-30$68.62/sh+10,438$716,256→ 78,962 total
Exercise/Conversion
Common Stock
2023-01-30$72.27/sh+11,861$857,194→ 80,385 total
Exercise/Conversion
Common Stock
2023-01-30$80.50/sh+14,374$1,157,107→ 82,898 total
Sale
Common Stock
2023-01-30$84.73/sh−14,374$1,217,909→ 68,524 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-01-30−5,644→ 0 total
Exercise: $83.58Exp: 2031-07-01→ Common Stock (5,644 underlying)
Sale
Common Stock
2023-01-30$84.73/sh−4,842$410,263→ 68,524 total
Sale
Common Stock
2023-01-30$84.70/sh−11,861$1,004,627→ 68,524 total
Exercise/Conversion
Common Stock
2023-01-30$74.78/sh+4,842$362,085→ 73,366 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-01-30−12,865→ 0 total
Exercise: $65.36Exp: 2028-04-08→ Common Stock (12,865 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-01-30−11,861→ 0 total
Exercise: $72.27Exp: 2029-01-03→ Common Stock (11,861 underlying)

Footnotes (8)

[F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
[F2]Includes an aggregate of 49,571 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
[F3]Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting on April 9, 2019 and the remainder vesting monthly over three years.
[F4]Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years.
[F5]Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years.
[F6]Beginning January 17, 2020, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2020 and the remainder vesting monthly over three years.
[F7]Beginning July 2, 2021, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years.
[F8]Beginning January 2, 2022, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

INCYTE CORP

CIK 0000879169

→

Entity typeother

Related Parties

filerCIK 0001736295

Filing Metadata

Form type: 4
Filed: Jan 31, 7:00 PM ET
Accepted: Feb 1, 4:00 PM ET
Size: 36.7 KB

View on SEC.gov